Citation Impact

Citing Papers

Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression
2006 Standout
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
2013 StandoutNobel
What is polypharmacy? A systematic review of definitions
2017 Standout
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Myasthenia Gravis
2016 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
A pilot cross-over study to evaluate human oral bioavailability of BCM-95®CG (BiocurcumaxTM), a novel bioenhanced preparation of curcumin
2008
Ulcerative Colitis
2011 Standout
Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD‐subgroup analyses across four randomized trials
2009
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
Curcumin in inflammatory diseases
2012
Adverse Reactions to Aspirin and Nonsteroidal Antiinflammatory Drugs (NSAIDs)
2003
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Treatment of Ulcerative Colitis with a Humanized Antibody to the α 4 β 7 Integrin
2005
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Diagnosis and Management of Autoimmune Hepatitis
2010
Neuromuscular junction disorders
2016
Immunomodulatory effects of curcumin: In-vivo
2008
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
2009 Standout
Anti-ulcer Activity of Curcumin on Experimental Gastric Ulcer in Rats and Its Effect on Oxidative Stress/Antioxidant, IL-6 and Enzyme Activities
2009
Adverse Reactions to Selective Cyclooxygenase-2 Inhibitors (Coxibs)
2004
Extracorporeal photopheresis for the treatment of refractory Crohnʼs disease: Results of an open-label pilot study
2009
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes
2010 Standout
An Examination of the Food Allergy Quality of Life Questionnaire Performance in a Countrywide American Sample of Children: Cross-Cultural Differences in Age and Impact in the United States and Europe
2016
The Antioxidant Response Element and Oxidative Stress Modifiers in Airway Diseases
2008
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
2011 Standout
Neutrophils and immunity: challenges and opportunities
2006 Standout
Inflammation and Colon Cancer
2010 Standout
Dermatological complications and safety of anti-TNF treatments
2009
Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis
2007
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
2008
Human Antichimeric Antibody in Children and Young Adults with Inflammatory Bowel Disease Receiving Infliximab
2004
Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells
2018
Myasthenia gravis
2019 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Immunomodulatory effects of curcumin in allergy
2008
The energy expenditure of normal and pathologic gait
1999 Standout
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Food allergen immunotherapy: Current status and prospects for the future
2016
Polypharmacy and Crohn's disease
2005
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
2017 Standout
Evaluation of Efficacy of Curcumin as an Add-on therapy in Patients of Bronchial Asthma
2014
Allergist-Reported Trends in the Practice of Food Allergen Oral Immunotherapy
2014
Fungi and allergic lower respiratory tract diseases
2012
The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance
1988
How culture shaped the human genome: bringing genetics and the human sciences together
2010 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
The Incidence and Management of Infusion Reactions To Infliximab: A Large Center Experience
2003
The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients
2003
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab
2011
Treatment for food allergy
2018
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis
2012 Standout
Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery
2013 Standout
Rehabilitation of the Geriatric Amputee*
1974
Agricultural Origins and Frontiers in South Asia: A Working Synthesis
2007 Standout
Curcumin: A Review of Its Effects on Human Health
2017 Standout
Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis
2006
The Reasonableness of John Locke's Majority
1996
Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers
2013
God, Locke, and Equality
2002 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Combination therapy in combating cancer
2017 Standout
Agricultural Origins and Frontiers in South Asia: A Working Synthesis
2006 Standout
Curcumin, an active component of turmeric (Curcuma longa), and its effects on health
2015 Standout
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
TNF‐mediated inflammatory disease
2007 Standout
The geographic hypothesis and lactose malabsorption
1978
Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing
2014
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
2019 Standout
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
2008 Standout

Works of Michael B. Levy being referenced

Immune response modulation by curcumin in a latex allergy model
2007
Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction
2002
Oral Immunotherapy for Peanut Allergy: Multipractice Experience With Epinephrine-treated Reactions
2014
Anaphylaxis to celecoxib
2001
Toxic Mold Syndrome
2004
Lactase deficiency in Mexican-American males
1972
Increased Rates of Early Adverse Reaction to Azathioprine in Patients with Crohn's Disease Compared to Autoimmune Hepatitis: A Tertiary Referral Center Experience
2005
Freedom, Property and the Levellers: the Case of John Lilburne
1983
Patient quality of life following induction of oral immunotherapy for food allergy
2015
REHABILITATION OF AMPUTEES WITH PROGRESSIVE VASCULAR DISEASE
1972
Rankless by CCL
2026